Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Capecitabine, Cisplatin and Imatinib in Patients With Unresectable or Metastatic Gastric Cancer.

NCT00601510 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT00601510
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00601510 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Capecitabine, Cisplatin and Imatinib in Patients With Unresectable or Metastatic Gastric Cancer.
Lead sponsor
Technical University of Munich
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2007
Completion date
January 31, 2012
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer